Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C9H16N4S2 |
| Molecular Weight | 244.38 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CNC(=S)NCCSCC1=C(C)NC=N1
InChI
InChIKey=FPBPLBWLMYGIQR-UHFFFAOYSA-N
InChI=1S/C9H16N4S2/c1-7-8(13-6-12-7)5-15-4-3-11-9(14)10-2/h6H,3-5H2,1-2H3,(H,12,13)(H2,10,11,14)
| Molecular Formula | C9H16N4S2 |
| Molecular Weight | 244.38 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
Approval Year
Targets
| Primary Target | Pharmacology | Condition | Potency |
|---|---|---|---|
Target ID: CHEMBL1941 |
|||
Target ID: CHEMBL2096683 Sources: https://www.ncbi.nlm.nih.gov/pubmed/6133770 |
|||
Target ID: P49189 Gene ID: 223.0 Gene Symbol: ALDH9A1 Target Organism: Homo sapiens (Human) Sources: https://www.ncbi.nlm.nih.gov/pubmed/9271349 |
122.0 µM [Ki] |
Conditions
| Condition | Modality | Targets | Highest Phase | Product |
|---|---|---|---|---|
| Primary | Unknown Approved UseUnknown |
PubMed
| Title | Date | PubMed |
|---|---|---|
| Constitutive activity and ligand selectivity of human, guinea pig, rat, and canine histamine H2 receptors. | 2007-06 |
|
| Degranulation of mast cells located in median eminence in response to compound 48/80 evokes adrenocortical secretion via histamine and CRF in dogs. | 2004-10 |
|
| Interactions among three classes of mediators explain antigen-induced bronchoconstriction in the isolated perfused and ventilated guinea pig lung. | 2003-10 |
|
| Heterologous expression of rat epitope-tagged histamine H2 receptors in insect Sf9 cells. | 1997-11 |
|
| Side effects of cimetidine. | 1979-05 |
|
| A comparison of the cardiovascular effects of centrally administered clonidine and adrenaline in the anaesthetized rat. | 1979-01 |
|
| Clonidine-induced hypotension: further evidence for a central interaction with histamine H2 receptor antagonists in the rat. | 1978-04-01 |
|
| [Treatment of peptic ulcer in the Zollinger-Ellison syndrome with histamine H2-receptor antagonists (author's transl)]. | 1977-11-25 |
|
| Some aspects of medical management of gastrointestinal disease. I. | 1975-01-25 |
Patents
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/234981
Patients with duodenal ulcers were stimulated by a steak meal, and acid secretion was measured by in vivo intragastric titration. Metiamide in a 400-mg dose produced no side effects and almost completely abolished food-stimulated acid secretion. A dose-response curve revealed that a 50-mg dose of metiamide was required to suppress food-stimulated acid secretion by 50%.
Route of Administration:
Oral
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/8514670
A study characterized the kinetics of and determined the mediators involved in antigen-induced contraction of pulmonary arteries (PA) and lung parenchyma isolated from actively sensitized guinea pigs. Ovalbumin (10(-2) mg/ml) induced contractions of PA rings, which reached maximum amplitude by 2 min and decayed to 50% of maximum by 4-6 min. Pyrilamine (10(-6) M) delayed the onset of contraction and decreased the peak of the response by > 50%. Metiamide (10(-4) M) partially reversed this effect.
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 18:10:10 GMT 2025
by
admin
on
Mon Mar 31 18:10:10 GMT 2025
|
| Record UNII |
3K7670861M
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Official Name | English | ||
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C29702
Created by
admin on Mon Mar 31 18:10:10 GMT 2025 , Edited by admin on Mon Mar 31 18:10:10 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
C90862
Created by
admin on Mon Mar 31 18:10:10 GMT 2025 , Edited by admin on Mon Mar 31 18:10:10 GMT 2025
|
PRIMARY | |||
|
METIAMIDE
Created by
admin on Mon Mar 31 18:10:10 GMT 2025 , Edited by admin on Mon Mar 31 18:10:10 GMT 2025
|
PRIMARY | |||
|
SUB08881MIG
Created by
admin on Mon Mar 31 18:10:10 GMT 2025 , Edited by admin on Mon Mar 31 18:10:10 GMT 2025
|
PRIMARY | |||
|
1548992
Created by
admin on Mon Mar 31 18:10:10 GMT 2025 , Edited by admin on Mon Mar 31 18:10:10 GMT 2025
|
PRIMARY | |||
|
307755
Created by
admin on Mon Mar 31 18:10:10 GMT 2025 , Edited by admin on Mon Mar 31 18:10:10 GMT 2025
|
PRIMARY | |||
|
3455
Created by
admin on Mon Mar 31 18:10:10 GMT 2025 , Edited by admin on Mon Mar 31 18:10:10 GMT 2025
|
PRIMARY | |||
|
CHEMBL275446
Created by
admin on Mon Mar 31 18:10:10 GMT 2025 , Edited by admin on Mon Mar 31 18:10:10 GMT 2025
|
PRIMARY | |||
|
DTXSID80188390
Created by
admin on Mon Mar 31 18:10:10 GMT 2025 , Edited by admin on Mon Mar 31 18:10:10 GMT 2025
|
PRIMARY | |||
|
34839-70-8
Created by
admin on Mon Mar 31 18:10:10 GMT 2025 , Edited by admin on Mon Mar 31 18:10:10 GMT 2025
|
PRIMARY | |||
|
DB08805
Created by
admin on Mon Mar 31 18:10:10 GMT 2025 , Edited by admin on Mon Mar 31 18:10:10 GMT 2025
|
PRIMARY | |||
|
D008785
Created by
admin on Mon Mar 31 18:10:10 GMT 2025 , Edited by admin on Mon Mar 31 18:10:10 GMT 2025
|
PRIMARY | |||
|
3K7670861M
Created by
admin on Mon Mar 31 18:10:10 GMT 2025 , Edited by admin on Mon Mar 31 18:10:10 GMT 2025
|
PRIMARY | |||
|
100000080910
Created by
admin on Mon Mar 31 18:10:10 GMT 2025 , Edited by admin on Mon Mar 31 18:10:10 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |